APOE and Alzheimer disease: The recent identification of the ApoE pathway as a driver of microglial phenotype alteration in AD (Krasemann et al., 2017) has casted further doubt on the usefulness of the classical dichotomous M1-M2 phenotype description (Ransohoff, 2016).